Cancer is currently considered to be one of the most dangerous conditions in the world. The disease has now surpassed all the modern time ailments, and it is now the greatest challenge to longevity. The condition is killing millions of people every day. Medical experts are working hard to bring a perfect cure that will reduce the effects of the disease on human beings. A lot of research is still going on as scientists try to come up with the best medicine. There are different types of cancers, and they affect different parts of the human body. It is evident that experts are in the right direction, and soon, people will be free from the deadly disease.
Clay Siegall is one of the most influential individuals in the cancer research world. Clay has been in the oncology world for a long time, and he has already introduced several changs to make the lives of people suffering from cancer better. Clay has served in several biotechnology companies in the past, and he has all the expertise needed to make the change needed. At the moment, he sits on several boards of directors.
Several years ago, Clay Siegall’s father was diagnosed with the deadly condition. The young man was forced to watch his father get weak every day because of the kind of treatment the father was getting. Instead of getting better and healthy, the medicine was only making him sicker and weak. This was when he decided to go back to school and study genetics. The scientist had already received a zoology degree from one of the respected universities in the world. After getting a Ph.D. in Genetics, Clay Siegall started to focus on cancer treatment therapies.
Clay founded a biotechnology company known as Seattle Genetics several years ago. Unlike most of the biotechnology companies in the modern times, the institution is led by a team of experienced oncologists who understand the right treatment to take so that an individual can get rid of cancer cells in the body. Clay works as the chief executive director of the biotechnology company, and his greatest responsibility is to make sure that cancer patients get the cure they are looking for. Siegall is also tasked with the capital raising activities of the institution.